Overview: Vancomycin TestIntroduction: The Vancomycin Test measures vancomycin levels to monitor antibiotic therapy, preventing infections. Following 2023 IDSA guidelines, it uses biochemical methods for high specificity, supporting drug monitoring. This test is critical for guiding therapy adjustments, treatment planning, and improving outcomes in biochemistry for patients with bacterial infections.
Other Names: Vancomycin Assay, Vancocin Level Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for therapeutic drug monitoring.
Historical Milestone: Vancomycin monitoring began in the 1980s with antibiotic research. Biochemical methods improved in the 2000s, enhancing precision.
Purpose: Measures vancomycin levels to monitor antibiotic therapy, guides dosing, and prevents infections.
Test Parameters: 1. Vancomycin Level
Pretest Condition: No fasting required. Collect serum or plasma. Report history of infections or vancomycin use.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document infections, fever, or history of vancomycin use. Include current medications, especially antibiotics.
Consent: Written consent required, detailing the tests purpose, infection treatment implications, and risks of sample collection.
Procedural Considerations: Uses liquid chromatography-mass spectrometry (LC-MS) to measure vancomycin levels. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for infection monitoring.
Factors Affecting Result Accuracy: Sample hemolysis or improper timing can affect results. Renal function may alter vancomycin levels.
Clinical Significance: Therapeutic vancomycin levels confirm effective infection control, guiding dose adjustments. Suboptimal levels may indicate poor efficacy or toxicity.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and dosing adjustments.
Additional Supporting Tests: Blood culture, renal function tests, or other antibiotic levels to monitor infection treatment.
Test Limitations: Non-specific for infection type; clinical correlation is needed. Sample timing affects accuracy.
References: IDSA Antibiotic Guidelines, 2023; Clinical Infectious Diseases, Rybak MJ, 2022.
